Winter 2010 Newsletter now available onlineThe latest edition of the TLC-RN newsletter is now available by clicking on the link below. More InformationFlexibility and Sustainability FundingApplications are invited for FSF funding from the TLCRN. More InformationChildren & Young Persons Advisory Group'Want to join a group of young people who advise on research into medicines for children & young people?' More Information
|
Research Process
Phase 1 In phase 1, only a few grown-ups try the medicine. No-one has tried the medicine before, so children are not allowed to try it. The grown-ups might not even be poorly! In phase 1, we find out how much it is safe to take. We also find out what happens to the medicine when it is inside the grown-ups. Phase 2 In phase 2, both children and grown-ups can take part. The people who take part may be poorly – if we think the new medicine will make them better. In phase 2, we find out how much medicine poorly people need to take to get better. We find out how the medicine works and how safe it is. We find out if the new medicine is better than other medicines. Phase 3 Phase 3 is like phase 2, but more people take part. This way, we can learn a lot more about the new medicine. At any phase, we might decide the medicine is not as good as we hoped, so we might stop trying it. Or, we might decide it is good for some people, but not as good for other people. At the end of phase 3, the new medicine might be sold in shops and used in hospitals if it is alright. Phase 4 |
| Homepage | Sitemap | Accessibility | |